Antibiotics

<p>Nortopixantrone(BBR 3438) is a novel 9-azacyclophenanthracene pyrazole that shows antitumor activity in a human prostate cancer model.</p>

<p>Swainsonine (Tridolgosir) is an alkaloid isolated from Astragalus membranaceus and is a potent and reversible inhibitor of alpha-mannosidase. swainsonine has antitumour activity and induces apoptosis and cell cycle arrest in the G2/M phase.</p>

<p>A 53868A is an antibiotic, it is isolated from Streptomyces luridus.</p>

<p>Antibiotic of anthracycline class; DNA synthesis inhibitor</p>

<p>Cefsulodin sodium salt is a beta lactam antibiotic in the third-generation cephalosporin family that inhibits penicillin-binding proteins (PBPs) to disrupt bacterial cell wall synthesis.</p>

<p>Ticarcillin disodium salt is a beta-lactam antibiotic that has in vitro activity against Gram-positive and Gram-negative bacteria. Ticarcillin is active against penicillinase-producing strains of Staphylococcus aureus, Enterobacter aerogenes, Proteus mirabilis, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Serratia marcescens, Streptococcus pyogenes, Streptococcus faecalis, and Streptococcus pneumoniae. Furthermore, it inhibits transpeptidase activity of the cell wall of bacteria which prevents peptidoglycan synthesis. It is bactericidal for many bacteria at low concentrations.</p>

<p>Amicoumacin A is an antibiotic compound, which is derived from the bacterium Bacillus subtilis. This natural source is known for its production of a variety of biologically active compounds that contribute to its utility in numerous scientific contexts. The mode of action of Amicoumacin A involves the inhibition of bacterial protein synthesis by targeting the ribosomal subunit. Specifically, it interferes with the translation process, effectively disrupting the growth and proliferation of susceptible bacterial strains.<br><br>Amicoumacin A is primarily utilized in research settings to study bacterial resistance mechanisms, as well as to explore novel antibacterial therapies. Its application in scientific research extends to examining its potential synergistic effects with other antimicrobial agents, and it serves as a model compound for understanding ribosomal inhibition. The study of Amicoumacin A not only contributes to the broader field of antibiotic development but also offers insights into the molecular interactions that underlie bacterial protein synthesis and antibiotic resistance. This compound's unique properties make it an important subject of investigation for microbiologists and pharmacologists alike, emphasizing its relevance in the ongoing battle against antibiotic-resistant pathogens.</p>

<p>Tobramycin is used to treat severe infections with gram-negative bacteria and it is often applied in combination with beta-lactams. It has similar antimicrobial effects to gentamicin and is effective against all Enterobacteriacae, but more effective than gentamicin against P. aeruginosa, which is why it is often used for gentamicin-resistant strains, especially in the case of cystic fibrosis.</p>

<p>Potassium clavulanate is a beta-lactamase inhibitor and an antibacterial agent. The presence of potassium clavulanate in culture media inhibits the activity of beta-lactamases, which are enzymes that confer resistance to penicillin and other beta-lactam antibiotics. It also has been shown to be active against bacterial infections such as tuberculosis, sepsis, and pneumonia, where it can inhibit the growth of bacteria by interfering with their ability to form cell walls. Potassium clavulanate is also used as an antimicrobial agent for blood culture technique and antimicrobial treatment.</p>

<p>DprE1-IN-8 is a potent inhibitor of DprE1, exhibiting an IC50 of less than 0.75 μM.</p>

PKUMDL-LTQ-301 is a potent inhibitor of HipA toxin. PKUMDL-LTQ-301 also inhibits E. coli persistence.